pd 131628 has been researched along with tosufloxacin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domagala, JM; Heifetz, CL; Priebe, SR; Sanchez, JP; Sesnie, JA; Trehan, AK | 1 |
| Bouzard, D; Di Cesare, P; Essiz, M; Fung-Tomc, J; Jacquet, JP; Kessler, RE; Ledoussal, B; Remuzon, P | 1 |
| Bauernfeind, A | 1 |
3 other study(ies) available for pd 131628 and tosufloxacin
| Article | Year |
|---|---|
Quinolone antibacterial agents. Synthesis and structure-activity relationships of a series of amino acid prodrugs of racemic and chiral 7-(3-amino-1-pyrrolidinyl)quinolones. Highly soluble quinolone prodrugs with in vivo pseudomonas activity.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Mice; Naphthyridines; Prodrugs; Pseudomonas; Quinolones; Stereoisomerism; Structure-Activity Relationship | 1992 |
Fluoronaphthyridines as antibacterial agents. 4. Synthesis and structure-activity relationships of 5-substituted-6-fluoro-7-(cycloalkylamino)-1,4-dihydro-4-oxo-1,8- naphthyridine-3-carboxylic acids.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Mice; Naphthyridines; Structure-Activity Relationship | 1992 |
Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1993 |